Skip to main content

Furiex Pharmaceuticals Inc (NASDAQ:FURX) Investor Files Lawsuit In Effort To Halt The Proposed Acquisition

  • If you purchased shares of Furiex Pharmaceuticals Inc (NASDAQ:FURX) and currently hold any of those NASDAQ:FURX shares, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

May 8, 2014 (Shareholders Foundation) - An investor, who currently holds shares of Furiex Pharmaceuticals Inc (NASDAQ:FURX) filed a lawsuit in effort to halt the takeover of Furiex Pharmaceuticals by Forest Laboratories, Inc. The plaintiff alleges that the defendants breached their fiduciary duties owed to NASDAQ:FURX stockholders by agreeing to sell Furiex Pharmaceuticals Inc too ch...



You must register (for free) or login to view the entire case.